Navigation Links
Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
Date:4/30/2008

LAKE FOREST, Ill., April 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the Bank of America 2008 Health Care Conference on Wednesday, May 14, 2008, at the Four Seasons Hotel in Las Vegas.

The presentation is scheduled to begin at 12:40 p.m. Pacific time on Wednesday, May 14, 2008. It will be open to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at http://www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site at 12:25 p.m. Pacific time on May 14, 2008. A replay will be available on the Hospira Web site approximately 24 hours after the live presentation, until May 21.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
5. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
6. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
7. Hospira Launches Generic Irinotecan Injection
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Hospira Acquires Sculptor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , Ad in Today,s Washington Post ...ewswire-USNewswire/ -- If the Catholic bishops ...tative measures we take for granted may be under t...ght to bear on the debate over healthcare reform h...Washington Post warns of the likely impact if tha...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ -- The...Italy) in conjunction with a team of doctors from ...a six-year long research study confirming that Pec...ted Linoleic Acid), an Omega-6 polyunsaturated fat...d which shows bioactive properties for humans. ,...
(Date:12/2/2009)..., , DALLAS, Dec. 2 Proving...the parts," Texas Health Harris Methodist Hospital...rine Corps Reserves Toys for Tots program to make ... families. The organizations are combining their ... and other non-perishable food items, culminating ...
(Date:12/2/2009)... Study finds myriad microbes in tobacco, but risk ...Day News) -- New research provides evidence that ...uding bacteria that cause respiratory disease. ,...ed out, the authors of the new study aren,t sure w...o bacteria is nothing new: Microbes surround us ev...
(Date:12/2/2009)..., BOSTON Alcoholic beverages popular among youth...th high youth readership than alcoholic drinks con...ately high youth exposure to such targeted alcohol... the Boston University School of Public Health, Jo... Virtual Media Resources who conducted the study -...
Breaking Medicine News(10 mins):Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3Health News:Texas Health Harris Methodist Hospital Southlake Joins With U.S. Marine Corps Reserves Toys for Tots to Spread Holiday Cheer 2Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:Alcohol companies target youths with magazine ads, new study shows 2
... pill that could give a longer lease of life to pa... when given along with chemotherapy drugs. Pa... Novacea lived for an average of an extra nine mon...f the vitamin without running the risk of side eff...
...cial transplantation—including the psychological a...e—a Working Party of the Royal College of Surgeons... in performing further face transplants, according...tation should not be attempted until further resea...
...vard School of Public Health (HSPH) finds that pol... in a net savings of over $180 billion, even witho...ated with avoided fear and suffering. This first s...of Risk Analysis. The history of polio vaccin...
... and gamblers in Britain. A study reveals// that E...inos then on vegetables and fruits. On an ave...ambling in United Kingdom. Online gambling has als...enagers getting addicted to this habit. An analysi...
...eans high pressure in the arteries. High blood pre...iller’ because one can have it for years without k...P when his blood pressure reading is around 120/80... Approx. 2.5 million Canadians have high-norm...
...e of the largest eye care hospital networks in sou...ith seven more in the offing. The Chennai fa...emraj, a prominent ophthalmic surgeon and managing...t for the eight hospitals. Fifty percent of the fu...
Other Medicine News:Health News:Royal College Issues Revised Guidelines for Face Transplantation 2Health News:Royal College Issues Revised Guidelines for Face Transplantation 3Health News:Billions of Dollars Saved in U.S. By Polio Vaccination 2Health News:Slightly High Blood Pressure is Also Hazardous 2
(Date:12/2/2009)... and NEW YORK, Dec. 2 In...U Langone Medical Center announced findings from a...sity on the genetics of osteoarthritis have been p...f the Annals of Rheumatic Diseases and is availabl...043v1.pdf . Results from the study highlight i...
(Date:12/2/2009)...Dec. 2 Novavax, Inc. (Na...ults from the first stage of a two-stage pivotal P...city of the company,s 2009 H1N1 virus-like particl...nducting this study in collaboration with Avimex L...he vaccine in Mexico and potentially other countri...
(Date:12/2/2009)..., Dec. 2 Adults are more likely .... For adults 65 and over, the odds of losing visio...loping prostate cancer are one in six and odds of ... Vision loss threatens the overall health of aging...sion and inability to complete daily tasks. ,, ...
Breaking Medicine Technology:Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Respiratory Issues Linger for Smallest Babies 51318 1Respiratory Issues Linger for Smallest Babies 51318 2More Mammograms May Mean More Harmless Cancers 51316 1More Mammograms May Mean More Harmless Cancers 51316 2NMB Expands in Canada 51314 1NMB Expands in Canada 51314 2
...o be Presented at Lymphoma Meeting in Lugano, Swit...el,today reported an abstract providing preliminar...Syk inhibitor, R788 (fostamatinib disodium), in,pa...kin,s lymphomas (NHL).,The abstract reports favora...mphocytic lymphoma/chronic lymphocytic leukemia (S...
... FRANCISCO, Calif., June 2 Rigel,Pharmaceuticals,...l host a,conference call with simultaneous webcast... clinical study of R788, a novel, oral Syk kinase,...ymphomas on Tuesday, June,3, 2008 at 8:00 a.m. EDT...anagement and the principal investigator on the st...
Other Medicine Technology:Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 2Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 3Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 4Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: